Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
The successful development of nonviral delivery systems for nucleic acids has been reported extensively over the past years. Increasingly employed to improve the delivery efficiency and therapeutic efficacy of RNA are lipid nanoparticles (LNPs). Many of the various critical formulation parameters ca...
Main Authors: | Lidia Gurba-Bryśkiewicz, Wioleta Maruszak, Damian A. Smuga, Krzysztof Dubiel, Maciej Wieczorek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/10/2752 |
Similar Items
-
Employing QbD strategies to assess the impact of cell viability and density on the primary recovery of monoclonal antibodies
by: Ole Jacob Wohlenberg, et al.
Published: (2023-02-01) -
Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD)
by: Isa Martins Fukuda, et al.
Published: (2018-11-01) -
Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering
by: Kakon Nag, et al.
Published: (2023-08-01) -
Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment
by: Lalintip Hocharoen, et al.
Published: (2021-05-01) -
The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect
by: Cristina-Ioana Barbalata, et al.
Published: (2022-09-01)